Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis

Introduction: Cancer patients have metabolic imbalances due to the disease, treatment and their complications. Increases in triglycerides and glucose profile and catabolism of protein have been described and are associated with inflammatory response as result of the tumor activity or necrosis. Obje...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adriana Garófolo, Priscila dos Santos Maia-Lemos
Formato: article
Lenguaje:EN
PT
Publicado: Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) 2020
Materias:
Acceso en línea:https://doaj.org/article/cedb8183dd7949d7ae9cea507216ac48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cedb8183dd7949d7ae9cea507216ac48
record_format dspace
spelling oai:doaj.org-article:cedb8183dd7949d7ae9cea507216ac482021-11-29T20:03:24ZLow Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis10.32635/2176-9745.RBC.2019v65n3.5280034-71162176-9745https://doaj.org/article/cedb8183dd7949d7ae9cea507216ac482020-01-01T00:00:00Zhttps://rbc.inca.gov.br/revista/index.php/revista/article/view/528https://doaj.org/toc/0034-7116https://doaj.org/toc/2176-9745 Introduction: Cancer patients have metabolic imbalances due to the disease, treatment and their complications. Increases in triglycerides and glucose profile and catabolism of protein have been described and are associated with inflammatory response as result of the tumor activity or necrosis. Objective: To evaluate the blood lipid, lipoproteins, glucose and albumin levels in pediatric cancer patients at diagnosis. Method: Observational cross-sectional study. The inclusion criteria were children and adolescents with newly diagnosed malignancies and blood analysis results. The exclusion criteria were: previous anticancer therapy or surgical treatment, blood sample not collected and patients who refused to participate in the study. Results: It were evaluated 81 children and adolescents with newly diagnosed malignancies. There was decrease of 56% and 41% of high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG), 14% and 10% of albumin and glucose, and 10% and 7.6% of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), respectively, for the patients. HDL-C showed statistical differences between solid and hematological cancer patients (p < 0.05). The means and medians of albumin, glucose, HDL-C and TG demonstrated that hematological patients are more prone to metabolic disturbances. HDL-C in this group was 24 ± 12 versus 40 ± 15mg/dl in other cancers. Conclusion: The primary result found in the present study was in HDL-C, mainly in patients with hematological and metastatic cancer. These disturbances could be associated with cancer-related acute inflammatory response. Adriana GarófoloPriscila dos Santos Maia-LemosInstituto Nacional de Câncer José Alencar Gomes da Silva (INCA)articleTriglycerides/bloodCholesterol, HDL/bloodBlood GlucoseSerum AlbuminNeoplasmsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENPTRevista Brasileira de Cancerologia, Vol 65, Iss 3 (2020)
institution DOAJ
collection DOAJ
language EN
PT
topic Triglycerides/blood
Cholesterol, HDL/blood
Blood Glucose
Serum Albumin
Neoplasms
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Triglycerides/blood
Cholesterol, HDL/blood
Blood Glucose
Serum Albumin
Neoplasms
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Adriana Garófolo
Priscila dos Santos Maia-Lemos
Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis
description Introduction: Cancer patients have metabolic imbalances due to the disease, treatment and their complications. Increases in triglycerides and glucose profile and catabolism of protein have been described and are associated with inflammatory response as result of the tumor activity or necrosis. Objective: To evaluate the blood lipid, lipoproteins, glucose and albumin levels in pediatric cancer patients at diagnosis. Method: Observational cross-sectional study. The inclusion criteria were children and adolescents with newly diagnosed malignancies and blood analysis results. The exclusion criteria were: previous anticancer therapy or surgical treatment, blood sample not collected and patients who refused to participate in the study. Results: It were evaluated 81 children and adolescents with newly diagnosed malignancies. There was decrease of 56% and 41% of high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG), 14% and 10% of albumin and glucose, and 10% and 7.6% of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), respectively, for the patients. HDL-C showed statistical differences between solid and hematological cancer patients (p < 0.05). The means and medians of albumin, glucose, HDL-C and TG demonstrated that hematological patients are more prone to metabolic disturbances. HDL-C in this group was 24 ± 12 versus 40 ± 15mg/dl in other cancers. Conclusion: The primary result found in the present study was in HDL-C, mainly in patients with hematological and metastatic cancer. These disturbances could be associated with cancer-related acute inflammatory response.
format article
author Adriana Garófolo
Priscila dos Santos Maia-Lemos
author_facet Adriana Garófolo
Priscila dos Santos Maia-Lemos
author_sort Adriana Garófolo
title Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis
title_short Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis
title_full Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis
title_fullStr Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis
title_full_unstemmed Low Levels of High-density Lipoprotein in Patients with Pediatric Cancer at Diagnosis
title_sort low levels of high-density lipoprotein in patients with pediatric cancer at diagnosis
publisher Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
publishDate 2020
url https://doaj.org/article/cedb8183dd7949d7ae9cea507216ac48
work_keys_str_mv AT adrianagarofolo lowlevelsofhighdensitylipoproteininpatientswithpediatriccanceratdiagnosis
AT prisciladossantosmaialemos lowlevelsofhighdensitylipoproteininpatientswithpediatriccanceratdiagnosis
_version_ 1718407131779039232